Celesio believes that pharmacists are ideally placed to make significant cost savings and outcomes improvements to support public healthcare budgets. One area where immediate savings are possible is pharmacist-led generic substitution.
This Policy Position Paper explains this concept and the advantages it offers to the long-term sustainability of Europe’s healthcare systems. We therefore call for appropriate legislative/policy measures to promote generic substitution at national level, and for EU-level policymakers to support this process.
- Ronan Brett
- Director Public Affairs McKesson Europe